Quantification of neutralizing anti-drug antibodies and their neutralizing capacity using competitive displacement and tandem mass spectrometry: Infliximab as proof of principle

BACKGROUND: The development of anti-drug antibodies (ADA) in patients treated with therapeutic proteins can result in treatment failure. The clinically most relevant fraction of these antibodies are the neutralizing anti-drug antibodies (NAb) that block the pharmacological function of the drug. Cons...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Autoimmun
Main Authors: El Amrani, Mohsin, Göbel, Camiel, Egas, Annelies C., Nierkens, Stefan, Hack, C. Erik, Huitema, Alwin D.R., van Maarseveen, Erik M.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Research paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7388346/
https://ncbi.nlm.nih.gov/pubmed/32743494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtauto.2019.100004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados